NCT01641939 2017-05-12
A Study of Trastuzumab Emtansine Versus Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer
Hoffmann-La Roche
Phase 2/3 Terminated
Hoffmann-La Roche
Auron Healthcare GmbH
Bristol-Myers Squibb
Eastern Network of Cancer Immunological Therapy, Japan